Dr. Tesi has been President, Chief Executive Officer and acting Chief Medical Officer of since September 2015. From November 2011 to May 2015, INmune Bio is a clinical stage biotech company formed to develop XPro1595 for the treatment of neurodegenerative disease and other inflammatory diseases. Dr. Tesi received his MD degree from Washington University School of Medicine in 1982. Dr. Tesi has been an academic transplant surgeon before joining industry.